XWELL, Inc. (XWEL)
| Market Cap | 7.29M-9.0% |
| Revenue (ttm) | n/a-7.6% |
| Net Income | n/a-21.1% |
| EPS | n/a-27.8% |
| Shares Out | 7.93M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,210.025 |
| Open | 0.92 |
| Previous Close | 0.90 |
| Day's Range | 0.89 - 0.93 |
| 52-Week Range | 0.26 - 2.20 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About XWEL
XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. customs and border protection agents; aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program; and various services and support, including technical support services and advanced services. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. It offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
$XWEL stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in XWEL holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by XWEL's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
XWEL Estimated quarterly lobbying spending
Source: U.S. Senate LDA
XWEL Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Disaggregation of Revenue | $7.14M | 50.94% |
| Expected revenue under contract | $6.88M | 49.06% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New XWEL patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to XWEL from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in XWEL
| ETF | Est. Holding Size |
|---|---|
| VXFVanguard Extended Market ETF | $47.16K |
Estimated from each fund’s disclosed top holdings × AUM
XWEL Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from XWEL’s recent data — informational, not investment advice